Waylis Therapeutics FDA Inspection Record
Waylis Therapeutics is an FDA-registered facility (FEI 3021614574) located in Rahway, NJ, US. Registered operations: LABEL; MANUFACTURE. RegDataLab tracks 1 FDA inspection at this facility.
What FDA found at this site
- Latest inspection
- Feb 12, 2026: Voluntary Action Indicated (VAI)
- Inspections on record
- 1 (1 VAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Form 483 and inspection documents
- 1 in FDA's reading room
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Feb 12, 2026 | Voluntary Action Indicated (VAI) | Failure to develop written procedures (21 CFR 314.80(b)) |
Form 483s and inspection documents
FDA record score
6 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
1 record behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Feb 12, 2026 | 6 x 1 | 6 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Waylis Therapeutics as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Waylis Therapeutics yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Waylis Therapeutics LLC
- Location
- Rahway, NJ (US)
- Registration Expires
- Dec 31, 2027
- Operations
- LABEL; MANUFACTURE
- Source
- decrs